Atlas FDA

PrismaSate BGK2/0 Dialysis Solution for Continuous Renal Replacement Therapy

FDA device recall Z-2049-2016 · posted 2016-06-24 · Terminated

Recall details

Recalling firm
Baxter Healthcare Corp.
Reason for recall
Presence of leaks near top of the PrismaSate bags
Action taken
Baxter Healthcare Corporation sent an Urgent Product Recall communication to affected customers via U.S.P.S. first class mail on 05/23/2016.
Root cause
Other
Status
Terminated
Product code
KPO
Quantity affected
10,054 units
Distribution
Distributed to Columbia and the following US states: AZ, CA, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WI
Date initiated
2016-05-23
Date posted
2016-06-24
Date terminated
2017-03-28
Location
Deerfield, IL

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
PRISMASATE DIALYSIS SOLUTIONS FOR CONTINUOUS RENAL REPLACEMENT THERAPY (K072908)Gambro Renal Products2008-02-04